127 related articles for article (PubMed ID: 16120422)
1. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease.
Aliev G; Smith MA; de la Torre JC; Perry G
Mitochondrion; 2004 Sep; 4(5-6):649-63. PubMed ID: 16120422
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G
J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
de la Torre JC
Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
[TBL] [Abstract][Full Text] [Related]
4. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.
Aliev G; Smith MA; Obrenovich ME; de la Torre JC; Perry G
Neurotox Res; 2003; 5(7):491-504. PubMed ID: 14715433
[TBL] [Abstract][Full Text] [Related]
5. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
Reddy PH
J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
[TBL] [Abstract][Full Text] [Related]
6. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease.
Blass JP; Gibson GE
Rev Neurol (Paris); 1991; 147(6-7):513-25. PubMed ID: 1962057
[TBL] [Abstract][Full Text] [Related]
7. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
[TBL] [Abstract][Full Text] [Related]
8. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
Sultana R; Perluigi M; Butterfield DA
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
Atamna H; Frey WH
Mitochondrion; 2007 Sep; 7(5):297-310. PubMed ID: 17625988
[TBL] [Abstract][Full Text] [Related]
10. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
[TBL] [Abstract][Full Text] [Related]
11. [The role of chronic brain hypoperfusion in the pathogenesis of Alzheimer's disease--facts and hypotheses].
Zádori D; Datki Z; Penke B
Ideggyogy Sz; 2007 Nov; 60(11-12):428-37. PubMed ID: 18198789
[TBL] [Abstract][Full Text] [Related]
12. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Calabrese V; Calvani M; Butterfield DA
J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
15. Why do Alzheimer's disease and Parkinson's disease target the same neurons?
Eggers AE
Med Hypotheses; 2009 Jun; 72(6):698-700. PubMed ID: 19250756
[TBL] [Abstract][Full Text] [Related]
16. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
Chen X; Yan SD
IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
Crouch PJ; Harding SM; White AR; Camakaris J; Bush AI; Masters CL
Int J Biochem Cell Biol; 2008; 40(2):181-98. PubMed ID: 17804276
[TBL] [Abstract][Full Text] [Related]
19. Pathological role of hypoxia in Alzheimer's disease.
Zhang X; Le W
Exp Neurol; 2010 Jun; 223(2):299-303. PubMed ID: 19679125
[TBL] [Abstract][Full Text] [Related]
20. Role of oxidative stress on beta-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: protection by antioxidants.
Montiel T; Quiroz-Baez R; Massieu L; Arias C
Exp Neurol; 2006 Aug; 200(2):496-508. PubMed ID: 16626708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]